Welcome to kongre.net
Speaker
Vice President, Head of Chemistry, BridGene Biosciences Inc.
Petr Jansa, Vice President, Head of Chemistry at BridGene Biosciences Inc., spoke at 4th Covalent Drug Discovery & Development Summit (Boston, United States of America, 20–22 Oct 2026) in the session “Proteome-Wide Live-Cell Covalent Screening Reveals Physicochemical Drivers of Promiscuous Labeling & Design Principles for Selective Covalent Libraries”.
20–22 Oct 2026Boston, United States of America
Executive Director, Aclaris Therapeutics
Associate Professor, Biological Chemistry & Molecular Pharmacology, Dana-Farber Cancer Institute
Associate Director, Chemical Biology & Proteomics, Dunad Therapeutics
Core Director, Dana-Farber Cancer Institute
Director, Eli Lilly
Director & Head of Discovery Biology, Frontier Medicines
This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Petr Jansa, and it lists only the talks, sessions and presentations named in those programmes.
Is this you? Claim this profile — every request is read by a person before anything is linked.
To ask for a correction or for this profile to be removed, email [email protected].